ADAM17 Silencing in Mouse Colon Carcinoma Cells: The Effect on Tumoricidal Cytokines and Angiogenesis-Reference-Cited by-同舟云学术

ADAM17 Silencing in Mouse Colon Carcinoma Cells: The Effect on Tumoricidal Cytokines and Angiogenesis

Published:2012-12-10 Issue:12 Volume:7 Page:e50791
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Das Sudipta,Czarnek Maria,Bzowska Monika,Mężyk-Kopeć Renata,Stalińska Krystyna,Wyroba Barbara,Sroka Jolanta,Jucha Jarosław,Deneka Dawid,Stokłosa Paulina,Ogonek Justyna,Swartz Melody A.,Madeja Zbigniew,Bereta Joanna

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference60 articles.

1. The ADAM metalloproteinases;DR Edwards;Mol Aspects Med,2008

2. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells;RA Black;Nature,1997

3. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha;ML Moss;Nature,1997

4. ADAM17 as a therapeutic target in multiple diseases;J Arribas;Curr Pharm Des,2009

5. ADAM17: a molecular switch to control inflammation and tissue regeneration;J Scheller;Trends Immunol,2011

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of cancer cell‐derived ADAM15 alters the tumor microenvironment in colorectal tumors;International Journal of Cancer;2023-08-21

2. Role of Some microRNA/ADAM Proteins Axes in Gastrointestinal Cancers as a Novel Biomarkers and Potential Therapeutic Targets—A Review;Current Issues in Molecular Biology;2023-04-03

3. ADAM10 and ADAM17 as Biomarkers Linked to Inflammation, Metabolic Disorders and Colorectal Cancer;Current Issues in Molecular Biology;2022-09-29

4. Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab;Diagnostics;2022-08-31

5. shRNAs targeting mouseAdam10diminish cell response to proinflammatory stimuli independently ofAdam10silencing;Biology Open;2022-03-04